• New Publication: ‘Multi-objective property optimisation of a phosphoserine-modified calcium phosphate cement for orthopaedic and dental applications using design of experiments methodology.’

    ,

    Biomimetic Innovations Ltd R&D Engineer Antzela Tzagiollari and the research team at DCU recently published a paper titled; ‘Multi-objective property optimisation of a phosphoserine-modified calcium phosphate cement for orthopaedic and dental applications using design of experiments methodology.’ This publication explains how their DoE approach successfully optimised the composition of OsStic®, demonstrating that the liquid: powder…

    Read More...

  • PBC Biomed Attends MÉDI’NOV CONNECTION Event.

    , ,

    PBC Biomed and Enterprise Ireland France joined forces at the MÉDI’NOV CONNECTION event in Lyon this morning, ahead of two days of networking and workshops. Pictured below from left to right are; John Shiel – Technology Development Advisor at EI, PBC Biomed Marketing Executive – Zahia Boukanoucha, Grace Kelly – Market Executive at EI France,…

    Read More...

  • PBC Biomed attend University of Limerick ‘Employer in Residence’ Exhibition Day.

    ,

    PBC Biomed is part of the University of Limerick‘s ‘Employer-in-Residence’ programme, allowing us to connect with students who are interested in pursing a career in Medical Devices, and would like to gain some experience within the area. Our HR specialist Ross Callaghan attended an Employer-in-Residence exhibition day last week with one of our UL Co-Op…

    Read More...

  • PBC Biomed recognised for contribution to Athlete Friendly Employer (AFE) programme by Sport Ireland.

    PBC Biomed were delighted to attend the Athlete Friendly Employer (AFE) Networking Breakfast, which took place at the heart of high-performance sport on the Sport Ireland Campus in Dublin last Friday. We were proud to be presented with a certificate of #recognition for our contribution to the AFE programme on the day. Pictured from left to right below is three-time…

    Read More...

  • PBC Biomed Clinical Advisory Board publish Editorial in Injury Journal.

    ,

    Part One of our ‘Strengthening the Bond’ symposium series at the Orthopaedic Trauma Association meeting in Tampa, focused on the unanswered challenges of osteosynthesis, as well as a first look at research on a promising new bio-adhesive. This surgeon panel, consisting of Professor Peter Giannoudis, Dr Tracy Watson, Dr Thomas A Russell, Dr Hassan Mir…

    Read More...

  • David Kelly, Research Scientist, celebrates 10 years with PBC Biomed.

    Congratulations to one of PBC Biomed‘s longest standing team members David Kelly, on celebrating 10 years with the company last week. Always ready to offer his insight and support, David has become a critical part of the R&D team since he joined the company a decade ago. Pictured is PBC Biomed’s CSO Gerard Insley, presenting David with his…

    Read More...

  • PBC Biomed Team in Memphis, February 2024.

    ,

    The PBC Biomed team are in Memphis this week, introducing our new Business Development manager David Sharp to our local network! If you are in the Downtown Memphis area and would like to say hi to David, Brittney, Elaine or Pierse, please feel free to stop by our office at Epicenter Memphis. The team will be there when they’re not sampling the local cuisine! #memphis#USoffice#newhire#businessdevelopment#pbcbiomed

    Read More...

  • DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.

    , , , ,

    Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®.  PBC Biomed leads a consortium for this development project, which is…

    Read More...

  • New Hire: David Sharp, US Business Development Lead.

    A very warm welcome to the newest member of the PBC Biomed team David Sharp, who has just joined as our US Business Development lead. David spent some time in our Irish headquarters this week to meet the extended team, however he will be based out of our US office at Epicenter Memphis. During his 25+ years working within…

    Read More...

  • ESTROT 2024

    ,

    PBC Biomed will be exhibiting at the 8th annual ESTROT Congress in Helsinki, Finland from 10-12th June. This year, the programme focuses on: Event information and registration is available here: https://www.estrot.org/eighth-estrot-congress-24.php

    Read More...